Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer

Hamouda Boussen*, Massimo Cristofanilli, Tal Zaks, Michelle DeSilvio, Vanessa Salazar, Neil Spector

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science